Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer

American Journal of Surgery

Volumn 196, Issue 1, 2008, Pages 81-87

  Yi, Min ^a   Krishnamurthy, Savitri ^a   Kuerer, Henry M ^a   Meric Bernstam, Funda ^a   Bedrosian, Isabelle ^a   Ross, Merrick I ^a   Ames, Frederick C ^a   Lucci, Anthony ^a   Hwang, Rosa F ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ductal carcinoma in situ; Metastasis; Microinvasive breast cancer; Sentinel lymph node dissection

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CARCINOMA IN SITU; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR BIOPSY; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; INCIDENCE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY;

EID: 45349101736     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.08.057     Document Type: Article

References (11)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 2 (2006) 106-130
2. Silverstein M.J., Lagios M.D., Craig P.H., et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 77 11 (1996) 2267-2274
3. Kelly T.A., Kim J.A., Patrick R., et al. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 186 4 (2003) 368-370
4. Cox C.E., Nguyen K., Gray R.J., et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am Surg 67 6 (2001) 513-521
5. Klauber-DeMore N., Tan L.K., Liberman L., et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol 7 9 (2000) 636-642
6. Pendas S., Dauway E., Giuliano R., et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7 1 (2000) 15-20
7. Wilkie C., White L., Dupont E., et al. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190 4 (2005) 563-566
8. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 4 (2005) 516-526
9. Black M.M., and Speer F.D. Nuclear structure in cancer tissues. Surg Gynecol Obstet 105 1 (1957) 97-102
10. Foster Jr. R.S. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin North Am 5 1 (1996) 79-104
11. Maffuz A., Barroso-Bravo S., Najera I., et al. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. J Exp Clin Cancer Res 25 2 (2006) 223-227